You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Profile for Philippines Patent: 12016500864


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12016500864

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 22, 2033 Astrazeneca LOKELMA sodium zirconium cyclosilicate
⤷  Get Started Free Oct 22, 2033 Astrazeneca LOKELMA sodium zirconium cyclosilicate
⤷  Get Started Free Oct 22, 2033 Astrazeneca LOKELMA sodium zirconium cyclosilicate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Philippines Drug Patent PH12016500864: Scope, Claims, and Patent Landscape Analysis

Last updated: August 13, 2025


Introduction

The patent number PH12016500864 pertains to a pharmaceutical invention registered in the Philippines. Understanding its scope, claims, and the broader patent landscape is critical for stakeholders aiming to navigate the Philippine intellectual property (IP) environment—be it for licensing, infringement analysis, or market entry. This analysis dissects the patent’s legal scope, the specificity of its claims, and positions it within the local and international patent environments, providing insights for strategic decision-making.


Patent Overview and Filing Context

The patent PH12016500864 was filed in the Philippines, likely under the country’s IP Code (Republic Act No. 8293). While the detailed filing documents are not publicly accessible here, typical pharmaceutical patents encompass compounds, formulations, or methods of use. The patent’s bibliographic data indicates a filing date in 2016, with a probable grant status as of the latest records.

In the Philippine system, patents grant exclusive rights for 20 years from the date of filing, provided maintenance fees are duly paid. The patent's scope hinges on the language of its claims, inherently defining the legal bounds of exclusivity.


Scope of the Patent

1. Patent Claims Analysis

Patent claims serve as the cornerstone of scope determination. Based on the typical structure of pharmaceutical patents, they likely include:

  • Composition Claims: Cover specific chemical entities or pharmaceutical compositions.
  • Use Claims: Cover specific methods of using the compound for therapeutic purposes.
  • Process Claims: Encompass methods of manufacturing the drug or preparing particular formulations.

Assuming the patent is related to a novel pharmaceutical compound or a novel use thereof, its claims likely focus on:

  • The chemical structure/compound that exhibits therapeutic benefits.
  • The unique formulation or delivery system.
  • The specific method of treatment or therapeutic indication.

While the actual claim set is not provided here, a typical patent in this domain will have a preamble, whereas clauses (if applicable), and a series of independent claims followed by dependent claims that add further specificity.

2. Claim Interpretation

The scope’s breadth hinges on whether the claims are broad or narrow:

  • Broad Claims: Cover a wide range of derivatives or uses, offering stronger protection but with higher patentability and validity challenges.
  • Narrow Claims: Specific to certain chemical variants or method steps, offering higher flexibility for competitors but potentially limited protection.

Given the constraints of Philippine patent law, which aligns with the European and US standards, claims that are supported by the initial disclosure and demonstrate inventive step are valid, but overly broad claims risk invalidation.

3. Patent Coverage and Limitations

  • Novelty: The claims must be distinguished from prior art, including existing drugs, publications, or prior patents.
  • Inventive Step: The claimed invention must not be obvious to a person skilled in the art.
  • Industrial Applicability: The claims must be applicable in a real-world manufacturing or therapeutic context.

The scope, therefore, depends on how well the claims delineate an inventive contribution and avoid prior art conflicts.


Patent Landscape in the Philippines for Pharmaceutical Patents

1. Local Patent Environment

The Philippines offers a relatively open but evolving patent landscape for pharmaceuticals. Notably:

  • The Philippine Patent Law adheres to international standards, with a focus on novelty and inventive step.
  • The Patent Law exceptions allow for prior use and compulsory licensing, which can impact enforcement.
  • The ongoing TRIPS compliance influences the scope of patent protection, especially for pharmaceuticals.

2. Patent Filings and Strategic Trends

Over recent years, the number of pharmaceutical patent applications in the Philippines has increased, aligning with regional trends in Asia-Pacific. Local filings often mirror international patent priorities, including:

  • Generic drug development: Patents may be challenged or invalidated based on local prior art, especially for known compounds.
  • Innovative formulations or delivery systems: Patents in this area tend to secure narrower claims, but with high enforceability.

3. Patent Thickets and Litigation

While patent litigation is less prevalent compared to Western jurisdictions, enforcement challenges exist due to:

  • Limited capacity for patent litigation.
  • Prevalence of patent opposition or invalidation proceedings.
  • The presence of compulsory licensing provisions allows the government to issue licenses in public health emergencies, impacting patent scope.

4. International Patent Landscape: GSK, Pfizer, and Local Players

Global pharmaceutical giants often file similar patents across jurisdictions, including the Philippines, to secure multiple layers of protection:

  • Patent families for core compounds.
  • Secondary patents on formulations, delivery methods, or use indications.

Smaller or local companies often focus on carve-outs or incremental innovations.


Implications for Stakeholders

1. Innovators and Patent Holders

Protection in the Philippines requires finely drafted claims that overcome local prior art and legal challenges. Proper prosecution can secure patent rights that block generic entry for 20 years, provided maintenance is timely.

2. Generic Manufacturers

Must monitor existing patents’ scope and validity, especially in composite claims, to avoid infringement or invalidation risks. Designing around patents—such as modifying compounds or delivery routes—is common.

3. Legal and Regulatory Authorities

Understanding the patent landscape ensures fair competition and public health safeguards, especially when compulsory licensing is invoked.


Conclusion

Scope and Claims

While exact claims for PH12016500864 are unavailable here, the patent’s scope fundamentally depends on meticulously crafted claims that clearly delineate the protected invention. These claims likely cover a particular pharmaceutical compound, formulation, or use, with the potential for narrow to moderate breadth depending on patent drafting strategies.

Patent Landscape

Philippine pharmaceutical patenting reflects a balance between fostering innovation and accommodating public health imperatives. The patent landscape is influenced by local legal provisions, existing prior art, international patent filing trends, and regional enforcement practices. Innovators must actively navigate these dynamics to maximize patent strength and enforceability.


Key Takeaways

  • A thorough review of the patent’s claims and their scope is essential for infringement, licensing, or validation purposes.
  • The Philippine patent environment encourages innovation but is also receptive to public health considerations, including compulsory licensing.
  • Patent drafting strategies should focus on achieving a balanced scope, compliant with local law, and resilient against invalidation.
  • Monitoring international patent families helps understand technological trends and potential threats or opportunities in the Philippines.
  • Local legal challenges and prior art can significantly influence patent enforceability; proactive patent prosecution and legal awareness are vital.

FAQs

1. What types of claims are typically found in pharmaceutical patents like PH12016500864?
Pharmaceutical patents generally encompass composition claims (chemical compounds/formulations), use claims (therapeutic methods), and process claims (manufacturing steps). The scope varies based on inventive contribution and strategic patent drafting.

2. How does Philippine patent law influence the scope of pharmaceutical patents?
Philippine law requires claims to be novel, non-obvious, and industrially applicable. The law also considers public health provisions that can impact patent enforcement, including compulsory licensing and pre-existing prior art.

3. Can a generic manufacturer challenge the validity of pharmaceutical patents in the Philippines?
Yes, under Philippine law, it is possible to challenge patents via opposition proceedings or invalidation actions, especially if prior art or lack of novelty/inventiveness is demonstrated.

4. How does the patent landscape in the Philippines compare to other jurisdictions?
While Philippines follows TRIPS standards, enforcement and litigation are less aggressive than in Western jurisdictions. Nonetheless, strategic patenting remains critical to safeguard innovations.

5. What strategic considerations should patent applicants keep in mind?
Applicants should draft claims with clear boundaries, ensure thorough prior art searches, and consider filing additional international patents. They should also remain aware of local legal exceptions and actively maintain their patents to prevent lapses.


References

[1] Philippine IP Code (Republic Act No. 8293).
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Philippine Intellectual Property Office (IPOPHL) Official Bulletins.
[4] International Patent Classification (IPC) standards in pharmaceuticals.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.